# Neonatal vitamin D status and asthma risk after age 5 years: A Danish population‐based cohort study

**Authors:** Xiaoqin Liu, Zhihong Zhu, Bo Chawes, Klaus Bønnelykke, Henriette Thisted Horsdal, Esben Agerbo, Sanne Grundvad Boelt, Nis Borbye‐Lorenzen, Lars Melgaard, Carsten Bøcker Pedersen, John J. McGrath

PMC · DOI: 10.1111/pai.70299 · Pediatric Allergy and Immunology · 2026-02-02

## TL;DR

This study found no link between vitamin D levels in newborns and asthma risk later in life, based on a large Danish cohort.

## Contribution

The study provides new evidence that neonatal vitamin D status and genetic predisposition to vitamin D levels are not associated with asthma risk.

## Key findings

- Neonatal 25(OH)D and DBP levels were not associated with asthma risk after age 5 years.
- Polygenic scores for asthma were linked to increased asthma risk, but scores for vitamin D traits were not.
- Analyses using tertiles confirmed no non-linear associations between vitamin D status and asthma.

## Abstract

Vitamin D may play a role in early lung development, yet epidemiologic evidence on its association with later asthma risk is mixed. We aimed to investigate the associations of neonatal 25‐hydroxyvitamin D (25(OH)D) and vitamin D‐binding protein (DBP) and their corresponding genetic predictors with asthma risk.

We conducted a population‐based cohort study of a random sample of individuals born in Denmark during 1991–2005 from the iPSYCH2012 study. Neonatal concentrations of 25(OH)D and DBP were measured via dried blood spots, and asthma cases were identified through diagnoses or asthma prescriptions after age 5 years. Cox regression was used to estimate hazard ratios (HRs) for asthma in relation to 25(OH)D, DBP, and polygenic scores (PGSs) for these traits and asthma to assess genetic liability to vitamin D status and asthma.

Of 14,005 individuals, 2308 (16.5%) developed asthma over a maximum follow‐up of 25 years. We found no association between neonatal 25(OH)D (HR = 1.04, 95% CI: 0.99–1.09 per SD increase) or DBP (HR = 1.01, 95% CI: 0.97–1.05) and asthma risk. Analyses using tertiles to assess potential non‐linear associations yielded similar null results. A higher asthma PGS was associated with increased asthma risk (HR = 1.42, 95% CI: 1.36–1.47 per SD increase), whereas PGSs for 25(OH)D (HR = 1.00, 95% CI: 0.96–1.05) and DBP (HR = 0.99, 95% CI: 0.95–1.04) were not.

Our study suggests that neonatal vitamin D status is not associated with asthma risk. Similarly, genetic liability related to vitamin D status, as reflected in PGSs for 25(OH)D and DBP, is not associated with an increased risk of asthma.

## Linked entities

- **Proteins:** DBP (D-box binding PAR bZIP transcription factor)
- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** GC (GC vitamin D binding protein) [NCBI Gene 2638] {aka DBP, DBP-maf, DBP/GC, GRD3, Gc-MAF, GcMAF}, DBP (D-box binding PAR bZIP transcription factor) [NCBI Gene 1628] {aka DABP, taxREB302}
- **Diseases:** asthma (MESH:D001249)
- **Chemicals:** Vitamin D (MESH:D014807), 25-hydroxyvitamin D (MESH:C104450), 25(OH)D (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929039/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929039/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929039/full.md

---
Source: https://tomesphere.com/paper/PMC12929039